What’s the status of the ByHeart botulism probe?

Outbreak declared over, investigation continues

Federal health officials have declared the botulism outbreak linked to a baby-formula maker to be over, but agencies are continuing investigations into how contamination occurred. The conclusion of the outbreak phase means no new linked illnesses have been reported in the latest surveillance period, but public-health bodies and regulators are still working to identify the root cause and any system failures that allowed the problem to arise.

Why the probe matters Botulism in infant formula is a high-priority safety event because infants are especially vulnerable to serious outcomes. Even after an outbreak is declared over, identifying the contamination pathway is crucial to preventing recurrence. Investigators typically examine manufacturing processes, ingredient sourcing, environmental controls, lab testing, and distribution records to trace how the toxin entered the product.

What families and providers should know - If you have infant formula from the company or lots that were previously flagged, follow official guidance about whether those products were recalled or should be discarded. - Consult a pediatrician if you have health concerns about an infant who consumed the product in question. - Continue to check updates from public-health agencies and the manufacturer for findings from the ongoing probe.

Longer-term implications The investigation’s findings could prompt industry-wide changes: tighter supplier audits, new testing requirements, changes to processing steps, or regulatory updates for formula production. Until the probe concludes, officials and manufacturers will likely focus on transparency, preventive measures, and restoring public confidence in infant-food safety.